Ekso Bionics (EKSO) to Release Quarterly Earnings on Monday

Ekso Bionics (NASDAQ:EKSO) is scheduled to be posting its quarterly earnings results after the market closes on Monday, April 29th. Analysts expect Ekso Bionics to post earnings of ($0.16) per share for the quarter.

Ekso Bionics (NASDAQ:EKSO) last issued its quarterly earnings data on Monday, March 4th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.11). The business had revenue of $4.85 million for the quarter, compared to analysts’ expectations of $4.80 million. Ekso Bionics had a negative return on equity of 90.80% and a negative net margin of 83.14%. During the same period in the previous year, the business posted ($0.24) earnings per share. On average, analysts expect Ekso Bionics to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Ekso Bionics Stock Down 3.0 %

Shares of NASDAQ:EKSO opened at $1.28 on Tuesday. Ekso Bionics has a fifty-two week low of $0.62 and a fifty-two week high of $3.13. The company has a quick ratio of 1.87, a current ratio of 2.49 and a debt-to-equity ratio of 0.38. The firm’s 50-day simple moving average is $1.57 and its 200-day simple moving average is $1.61. The company has a market cap of $22.91 million, a price-to-earnings ratio of -1.16 and a beta of 1.61.

Analyst Ratings Changes

A number of research analysts have recently issued reports on EKSO shares. HC Wainwright dropped their price target on shares of Ekso Bionics from $10.00 to $9.25 and set a “buy” rating on the stock in a research note on Tuesday, March 5th. StockNews.com upgraded shares of Ekso Bionics from a “sell” rating to a “hold” rating in a research note on Thursday, April 4th.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.